Prenetics Global (PRE) Cash & Equivalents (2021 - 2026)

Prenetics Global (PRE) has reported Cash & Equivalents for 6 consecutive years, with $56.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 29.81% year-over-year to $56.0 million; the TTM figure through Mar 2026 stood at $56.0 million (up 29.81% YoY), while the FY2025 annual figure was $32.1 million, down 38.51% from the prior year.
• Cash & Equivalents improved to $56.0 million in Q1 2026 per PRE's latest filing, from $7.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $177.2 million in Q2 2023 and bottomed at $7.8 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $71.7 million across 5 years, with a median of $49.2 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents surged 385.7% — and 2025, when it slumped 84.03%.
• Prenetics Global's Cash & Equivalents stood at $146.7 million in 2022, then slumped by 68.84% to $45.7 million in 2023, then increased by 7.54% to $49.2 million in 2024, then plunged by 84.03% to $7.8 million in 2025, then jumped by 613.85% to $56.0 million in 2026.
• Business Quant data shows PRE's Cash & Equivalents at $56.0 million in Q1 2026, $7.8 million in Q4 2025, and $13.3 million in Q3 2025.